Helen K. Ellias

Insider Reports History

Location
Sioux Falls, SD
Signature
/s/ Katie Ellias
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Helen K. Ellias:

Company Role Class Num Shares Value Price $ Report Date Ownership
SAB Biotherapeutics, Inc. Director Stock Option (right to buy) 150,000 16 Dec 2025 Direct

Insider Reports Filed by Helen K. Ellias

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SABS SAB Biotherapeutics, Inc. 16 Dec 2025 1 $0 4 Director 18 Dec 2025, 16:45
SABS SAB Biotherapeutics, Inc. 01 Nov 2024 2 $0 4 Director 05 Nov 2024, 16:41
SABS SAB Biotherapeutics, Inc. 24 Nov 2023 2 -$1,800,000 4 Director 28 Nov 2023, 16:05
SABS SAB Biotherapeutics, Inc. 14 Nov 2023 0 $0 3 Director 22 Nov 2023, 16:30